瘤-免疫细胞交叉声驱动免疫细胞重编程到一个支持瘤的增殖状态,涉及STAT3激活
Karen Norek1, Jacob Kennard1, Kenneth Fuh1
1Syantra Inc., 32 Royal Vista Drive NW, Suite 105, Calgary, AB T3R 0H9, Canada.
Cancers
|January 10, 2026
概括
癌细胞重新编程免疫细胞,促进瘤生长. 抑制STAT3信号传递可以逆转这种免疫细胞转化,为癌症治疗提供了一种新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 瘤诱导的免疫重编程是免疫逃避和疾病进展的关键癌症机制.
- 瘤微环境 (TME) 通过免疫细胞调节促进癌症转移和免疫逃避.
- 了解瘤-免疫细胞相互作用对于开发新型癌症疗法至关重要.
研究的目的:
- 研究三阴性乳腺癌 (TNBC) 细胞对单细胞表型和功能的影响.
- 为了确定参与瘤诱导的免疫细胞重编程的信号通路.
- 评估针对这些途径进行癌症治疗的治疗潜力.
主要方法:
- 使用THP1单细胞和TNBC细胞系 (MDA-MB-231,BT-549) 的共同培养模型.
- 单细胞直接或间接通过瘤条件介质暴露于癌细胞.
- 转录和通路分析以评估基因表达变化.
- 功能性试验用于测量单细胞增殖和细胞因子的产生.
- 使用STAT3-IN-12.使用STAT3信号的药理抑制.
主要成果:
- 暴露于癌症的单细胞表现出重新编程的表型,并激活了前瘤源途径.
- 在单细胞中观察到促炎性细胞因子 (包括IL6) 的表达升高.
- 在直接和间接的瘤暴露下,单细胞增殖的显著增加.
- STAT3抑制剂STAT3-IN-12有效抑制了由瘤驱动的单细胞增殖.
- 确定STAT3信号传递是免疫细胞转化的关键调解者.
结论:
- 向瘤培养的转录程序代表了癌症治疗中的新型免疫调节策略.
- 药物抑制STAT3可以恢复免疫细胞平衡,并抑制前瘤表型.
- 这种方法可以通过抵消瘤驱动的免疫失调来补充现有的癌症治疗方法.
- 这项研究提供了对免疫细胞可塑性的见解,并确定了可行的治疗点.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K


